Sanofi, Formation Bio and OpenAI Declare AI Partnership For Drug Development

Sanofi, Formation Bio and OpenAI are teaming up to construct AI-powered software to speed up drug advancement and carry new medicines to patients efficiently. The three groups will unite information, programming and tuned models to foster custom...

Dr Reddy's Labs and Alvotech Ink Pact To Commercialize Denosumab Biosimilar

Dr Reddy's Labs SA has forayed into a license and supply contract with Iceland-based biotech player Alvotech for the commercialisation of AVT03, the latter’s denosumab biosimilar candidate. ATV03 is a biosimilar candidate for Prolia and Xgeva...

MediciNova To Secure US patent For Prevention of Metastasis of Eye Cancer

MediciNova, Inc., a biopharmaceutical firm, stated that it has obtained a Notice of Allowance from the US Patent and Trademark Office for a pending patent application covering MN-166 (ibudilast) for the prevention of metastases in eye cancer...

Glenmark and BeiGene form Agreement For Distribution of Oncology Medicines

Glenmark Specialty S.A. (Glenmark), a subsidiary ofGlenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced an exclusive marketing and distribution agreementwith BeiGene, a global oncology company. Under this...

China NMPA Sanctions Zai Lab & Innoviva Specialty's Xacduro For HABP/VABP

Zai Lab Limited, a biotechnology firm, and Innoviva Specialty Therapeutics declared that Zai Lab’s New Drug Application (NDA) for Xacduro (sulbactam-durlobactam) has been approved by China’s National Medical Products Administration (NMPA) for the...

AstraZeneca Proposes USD 1.5 Billion Manufacturing Facility

AstraZeneca, a pharmaceutical firm, expects to construct a $1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), upgrading the worldwide stockpile of its ADC portfolio. ADCs are cutting-edge therapies that potent...

Implicity Bags US FDA Nod For New heart failure Prediction Algorithm

Implicity announced that company has received 510(k) clearance from the US Food and Drug Administration (FDA) for SignalHF, a new groundbreaking algorithm used in its remote monitoring solution. Implicity was the first...

Glenmark Pharma Bags US FDA Nod For Ophthalmic Solution

Glenmark Pharmaceuticals Ltd. (Glenmark) has acquired final approval from the US Food and Drug Administration (FDA) for brimonidine tartrate and timolol maleate ophthalmic solution, 0.2%|0.5%. The FDA has decided that Glenmark's brimonidine...

Roche Bags US FDA Nod for its human papillomavirus self-collection solutions

Roche reported that its human papillomavirus (HPV) self-collection solution, which was among the first available in the United States, has been approved by the US FDA. Screening for HPV can assist identify women who are at risk of getting...

Glenmark amplifies Nationwide Heart Health Initiative with the Next Phase of ‘India First Heart First’ Campaign

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceuticals company, proudly announced the launch of the next phase of ‘India First Heart First’ campaign.

© 2024 India Pharma Outlook. All Rights Reserved.